Johnson & Johnson Submits Guselkumab Application to FDA for

The submission could grant guselkumab its third indication, after being approved by the FDA for psoriasis and psoriatic arthritis.

Related Keywords

Jessica Allegretti , David Lee , Walterk Jessica Allegretti , Kunzmannk Guselkumab , Drug Administration , Johnson , American College Of Gastroenterology , Biologics License Application , Disease Week , American College , Scientific Meeting , Quasar Study , Published May , Benefits Ulcerative Colitis Regardless , Patient Treatment , Published October , Fda , Guselkumab , Quasar , Ulcerative Colitis , Uc , Submission , Johnson Amp ,